GREENVILLE, SC, March 17, 2020: Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has been nominated as a finalist for the Buzz of BIO Contest, which recognizes the most innovative companies in the life sciences.
BIO is the world’s largest biotech association. Among other conferences, the association sponsors the 2020 BIO International Convention each year, with almost 20,000 attendees. It takes place in San Diego this year in June, where the winner of Buzz of BIO will be announced.
Voting will run from March 17th at 9:00 am until March 19th at 5:00 pm—the general public is welcome to vote at https://www.bio.org/events/bio-international-convention/buzz-bio-voting.
Each finalist was asked to submit the three compelling reasons to vote for them. Zylö’s reasons are summarized as follows:
1. Zylö’s endocannabinoid-loaded Z-pod™ solution is showing striking results in a lupus model... Lupus affects women and people of color disproportionately and has tragic quality-of-life ramifications.
2. Our nitric-oxide-releasing Z-pod™ topical solution is showing compelling results in an Erectile Dysfunction model (where ED is secondary to prostatectomy, a condition that is not treatable with Viagra et al.); this solution should translate well as a treatment for older women with sexual dysfunction.
3. Our technology is disruptive and affordable... and we plan on keeping it that way.
Scott Pancoast, Zylö CEO and founder, stated “This is a huge honor and reflects the incredible innovation taking place in our lab from Andrew Draganski PhD, scientific founder, and scientists Eric Renne (M.S., U.C.) and Clay Tucker (M.S., Clemson). We encourage folks in the Upstate to vote in an effort to continue this region’s winning ways in the world of technological innovation.”
About Zylö Therapeutics: Zylö has developed a breakthrough topical delivery system that extends the duration-of-effect, improves the solubility/targeting, and/or enhances the product performance of many therapeutic agents. Notably, the Z-pod™ technology platform has enabled the Patchless Patch™ concept and has successfully harnessed the therapeutic potential of nitric oxide, one of the most powerful—and short-lived—biomolecules produced by our bodies. For more details please visit our web site, www.zylotherapeutics.com and follow us on Twitter (@ZyloTherapies).
SCBIZtv is part of the SC Biz News family, serving 100,000 high-level business execs throughout South Carolina. Click for more from SCBIZtv.